-
A new class of hemophilia drugs.
Is the mentioned drug registered anywhere in the world?
-
5 Replies
-
Hi Milos, May I ask which drug you are referring to? Are you talking about the recent news regarding gene therapy?
-
Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma.
-
Milos, Iām doing some research and will get back to you soon š
-
Hi Milos,
I have reached out to a few clinicians about your question, and they have no information to share. I will keep my ears open and ask that you do the same.Thank you!! Have a great week, Milos š
-
Thank you, Cazandra.
-
Milos, there is no anti-activated protein C (anti-APC) drug on the on the market in any country. ApcinteX Ltd and Centessa Pharmaceuticals are testing (phase 1/2 clinical trial) an anti-APC drug called SerpinPC (clinical trial # NCT04073498), with results expected in October 2023. See press release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-positive-topline-data-proof
Log in to reply.